Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemagglutinin Glycoprotein (H10N8) (HA (H10N8))
- Target
- HA (H10N8)
- Molecular classification
- Glycoprotein, Viral Surface Antigen
01
Overview
The hemagglutinin glycoprotein from influenza A(H10N8) is a trimeric surface antigen essential for viral entry. It exhibits genetic diversity allowing adaptation across species barriers—including humans—and remains an important focus of surveillance due its pandemic potential. Its structure-function relationship underpins much current research into vaccines and therapeutics targeting emerging influenza threats.
- Other names
- H10N8 HemagglutininInfluenza A H10N8 HAHA glycoprotein (H10N8)
02
Mechanism of action
Receptor binding to sialic acid residues on host cells, followed by conformational change and membrane fusion to facilitate viral entry.
03
Biological functions
Viral entryReceptor binding (sialic acid)Membrane fusionImmune response elicitation
04
Disease associations
Influenza A (H10N8) infectionRespiratory diseaseZoonotic disease
05
Safety considerations
Antigenic drift (mutation leading to reduced antibody binding)Potential for pandemic spread due to zoonotic natureDevelopment of resistance to antiviral drugs
06
Interacting drugs
NA inhibitors (e.g., Oseltamivir, Zanamivir) - indirectly, by preventing viral release
1 more in the full profile.
Beyond the preview
Go deeper on Hemagglutinin Glycoprotein (H10N8) (HA (H10N8)).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hemagglutinin Glycoprotein (H10N8) (HA (H10N8)).